scholarly journals Unconventional Treatment of a Giant Coronary Aneurysm Presenting as St-Elevation Myocardial Infarction: A Case Report

Author(s):  
Alberto Barioli ◽  
Nicola Pellizzari ◽  
Luca Favero ◽  
Carlo Cernetti

Abstract Background The optimal treatment of aneurysmal or ectatic culprit vessels in the setting of acute myocardial infarction is still matter of debate, as revascularization with either percutaneous intervention or surgery is associated with low procedural success and poor outcomes. Case Summary We report the case of a 55-year-old male patient, admitted for inferior ST-elevation myocardial infarction, who underwent successful percutaneous implantation of a micro-mesh self-expanding nitinol carotid stent in a right coronary aneurysm with IVUS-measured diameter of 9 mm and massive thrombus apposition. Discussion The technical characteristics of the micro-mesh self-expanding nitinol carotid stent allow for adequate plaque coverage and good apposition even in large vessels, making this device particularly suitable for the treatment of coronary lesions with high thrombus burden, when severe coronary ectasia or aneurysms are present.

2016 ◽  
Vol 68 (18) ◽  
pp. B21
Author(s):  
Pablo Salinas ◽  
Hernán Mejía-Rentería ◽  
Raul Herrera-Nogueira ◽  
Maria Del Trigo ◽  
Luis Nombela Franco ◽  
...  

2009 ◽  
Vol 31 (5) ◽  
pp. 581-581 ◽  
Author(s):  
Luis Diaz de la Llera ◽  
Nieves Romero-Rodriguez ◽  
Jose Miguel Borrego Dominguez

2021 ◽  
Vol 25 (12) ◽  
pp. 922-923
Author(s):  
Stefania Cherubini ◽  
◽  
Alessandro Sciahbas ◽  
Maria Cera ◽  
Silvio Fedele ◽  
...  

Diseases ◽  
2018 ◽  
Vol 6 (4) ◽  
pp. 104
Author(s):  
Hye Choi ◽  
Christina Luong ◽  
Anthony Fung ◽  
Teresa Tsang

Coronary artery ectasia (CAE) is localized or diffuse dilatation of the coronary artery lumen exceeding the diameter of adjacent healthy reference segments by 1.5 times. It is a rare phenomenon and incidence ranges from 1 to 5% in patients undergoing angiography. We report a case of a 58-year-old man with atherosclerotic CAE who experienced ST-elevation myocardial infarction (STEMI) despite prophylactic antiplatelet therapy. He was successfully treated with IV eptifibatide and aspiration thrombectomy. We reviewed the literature of CAE presentation, etiology and treatment and discussed the most appropriate antithrombotic therapy to prevent STEMIs in patients with CAE. While the current literature appears to favour prophylactic antiplatelet and anticoagulant in these patients, more studies are needed to determine the optimal form and duration of antithrombotic therapy. Currently, there is no gold standard treatment for CAE and further prospective and randomized-controlled studies are needed to guide recommendations.


Sign in / Sign up

Export Citation Format

Share Document